Back to search
Mechanisms of acquired resistance to the orally active platinum-based anticancer drug bis-acetato-ammine-dichloro-cyclohexylamine platinum (i.v.) (JM216) in two human ovarian carcinoma cell lines.
Data up to Jan 2025
Published1994
Citations34
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
No citing papers found in database